Image Source : Moneycontrol
Shilpa Medicare Ltd. has announced a strategic stake sale in Sravathi Advance Process Technologies, valued at approximately ₹49.6 crore (496 million rupees). The deal involves the company divesting a 31% stake, bringing in new investors and potentially strengthening its focus on core pharma operations.
Show more
Major Developments & Highlights
-
Significant stake sale: Shilpa Medicare sells 31% in Sravathi Advance Process Technologies for ₹49.6 crore, indicating confidence from new strategic investors.
-
Valuation details: The transaction values the stake at nearly ₹496 million, reflecting the company's growth prospects and strategic priorities.
-
Strategic significance: The stake sale aims to optimize the company's portfolio and bring in new expertise and resources for Sravathi's R&D activities and operations.
-
Company focus: Shilpa Medicare continues to emphasize its core business, including API manufacturing, formulation, biologics, and R&D initiatives, amid ongoing corporate restructuring.
-
Recent activity: The firm recently announced a bonus issue of shares, doubling its paid-up capital, which signals confidence in future growth.
Key Takeaway
This stake sale highlights Shilpa Medicare's strategic move to streamline operations while attracting new partners to accelerate its R&D and manufacturing capabilities, aligning with its long-term growth strategy. The company remains focused on expanding its global presence, backed by recent bonus issues and strategic investments.
Source: Data from NSE and BSE circulars, latest updates dated October 27, 2025.
Stay Ahead – Explore Now!
Dilip Buildcon Secures ₹983 Million Settlement with NHAI, Boosting Infrastructure Sector Confidence
Advertisement
Advertisement